Reapplix Reapplix is a biotech company that specializes in the biological treatment and management of diabetic foot ulcers. | ![]() GlySens GlySens is a company developing continuous glucose monitoring technology for patients with diabetes. | ||
Founding Date | Founding Date 2011 | Founding Date 2008 | Founding Date 1998 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Grenoble, FR HQ Paris, FR | Locations Birkerød, DK HQ Southlake, US | Locations San Diego, US HQ |
Employees | Employees 911% decrease | Employees 36 | Employees 5 |
Funding | |||
Latest funding round | Latest funding round $ 34.3m (over 6 years ago) | Latest funding round N/A | Latest funding round $ 20m (over 10 years ago) |
Total funding raised | Total funding raised $ 53.7m | Total funding raised $ 1.7m | Total funding raised $ 34m |
Reapplix is a biotech company that specializes in the biological treatment and management of diabetic foot ulcers.
View company
GlySens is a company developing continuous glucose monitoring technology for patients with diabetes.
View company